Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy

By Chen H-W.  

International Immunology, Vol. 15, Iss. 3, 2003-03 ,pp. : 427-435

Oxford University Press

Access to resources Recommend Favorite

Requirement of tumor-associated antigen-specific CD4 + T cells for an efficient dendritic cell vaccine in antitumor immunotherapy

By Simon Thomas   Fonteneau Jean-François   Grégoire Marc  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 565-567

Future Medicine

Access to resources Recommend Favorite

Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation

By Spiotto M.T.   Fu Y.-X.   Schreiber H.  

Current Opinion in Immunology, Vol. 15, Iss. 6, 2003-12 ,pp. : 725-730

Elsevier

Access to resources Recommend Favorite

B cell-mediated down-regulation of IFN-γ and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state

By Wijesuriya R.   Maruo S.   Sou J-P.   Ogawa M.   Umehara K.   Yamashita M.   Ono S.   Fujiwara H.   Hamaoka T.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1057-1065

Oxford University Press

Access to resources Recommend Favorite

Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation

By Bleakley Marie   Turtle Cameron J   Riddell Stanley R  

Expert Review of Hematology, Vol. 5, Iss. 4, 2012-08 ,pp. : 409-425

Informa Healthcare

Access to resources Recommend Favorite